Medicure Inc (MPH.V) Buy, Sell or Hold

Medicure Inc (MPH.V)

1.04

-0.04 (3.70%)

as of Jun 8, 2026, 1:35:59 pm Market Open.

7 watching

COMMENT

$0.33 of earnings in 2016 is expected to more than double. Roughly a median estimate of $.82 against $10.45, about a 13X PE multiple. It has existing drugs with sales related to that.

WEAK BUY

Just improved their cash position through a share sale. Have been approved in Canada to begin phase two trials for a hypertension product as well as being in phase two for their lead product. Well-positioned. Some technical concerns.

TRADE

Up 155% year-to-date and 12% on a 52-week basis. It's topping out now, finding a base. Having good support in the $1.50/1.60 range. Has about $10 million in cash, which is sufficient to get them through 2005. No revenue. Good partnerships.

Showing 1 to 3 of 3 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Medicure Inc (MPH.V) Frequently Asked Questions

What is Medicure Inc stock symbol?

Medicure Inc is a Canadian stock, trading under the symbol MPH.V (previously MPH-X on Stockchase) on the TSX Venture Exchange (MPH-CV). It is usually referred to as TSXV:MPH or MPH.V

Is Medicure Inc a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on MPH.V (previously MPH-X on Stockchase) on Stockchase. Read the latest expert commentary for Medicure Inc.

Is Medicure Inc a good investment or a top pick?

Medicure Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Medicure Inc.

Why is Medicure Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Medicure Inc.

Is Medicure Inc worth watching?

Medicure Inc is followed by 7 investors on Stockchase and is a trending stock that is worth watching.

What is Medicure Inc stock price?

On 2026-06-08, Medicure Inc (MPH.V) stock closed at a price of $1.04.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Medicure Inc (MPH.V)